This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Singapore Health Services Pte Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Gemmy Chui Ming Cheung in Retinal Treatment
Introduction
Gemmy Chui Ming Cheung is an accomplished inventor based in Singapore, known for his significant contributions to the field of medical treatments. He has developed a patented method aimed at addressing retinal angiogenic diseases, showcasing his dedication to advancing healthcare solutions.
Latest Patents
Cheung holds a patent for Angio-3, a groundbreaking treatment for retinal angiogenic diseases. This patent outlines a method of treating such conditions by administering an effective amount of an Angio-3 peptide. This innovative approach has the potential to improve the quality of life for patients suffering from these debilitating eye conditions.
Career Highlights
Cheung is affiliated with Singapore Health Services Pte Ltd, where he continues to work on innovative healthcare solutions. His role in this organization allows him to collaborate with other professionals in the medical field, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include Michael Belkin and Veluchamy Amutha Barathi, who contribute to the collaborative environment that fosters innovation and research in their projects.
Conclusion
Gemmy Chui Ming Cheung's work in developing Angio-3 exemplifies the impact of innovation in medical treatments. His contributions are vital in the ongoing fight against retinal diseases, and his collaborations with esteemed colleagues further enhance the potential for future advancements in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile